.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The VISION analysis showed that postoperative myocardial injury detected by high-sensitivity troponin testing is common and strongly associated with short-term mortality after noncardiac surgery. The study helped establish the concept of myocardial injury after noncardiac surgery as a clinically important perioperative syndrome rather than relying only on symptomatic myocardial infarction. The practical implication is that a patient can have clinically meaningful myocardial injury without chest pain or another obvious cardiac presentation. For surgical teams, this supports a more systematic approach to postoperative cardiovascular risk assessment in selected high-risk patients. Troponin interpretation should be linked to the clinical context because chronic elevation and nonischemic causes can complicate interpretation. Nevertheless, the study demonstrated that even modest postoperative troponin elevations contain prognostic information. Better recognition may allow earlier identification of patients who need closer monitoring, cardiovascular assessment and optimization of modifiable risk factors. VISION therefore helped broaden the perioperative safety focus beyond the operating room and into the first days after surgery.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The VISION analysis showed that postoperative myocardial injury detected by high-sensitivity troponin testing is common and strongly associated with short-term mortality after noncardiac surgery. The study helped establish the concept of myocardial injury after noncardiac surgery as a clinically important perioperative syndrome rather than relying only on symptomatic myocardial infarction. The practical implication is that a patient can have clinically meaningful myocardial injury without chest pain or another obvious cardiac presentation. For surgical teams, this supports a more systematic approach to postoperative cardiovascular risk assessment in selected high-risk patients. Troponin interpretation should be linked to the clinical context because chronic elevation and nonischemic causes can complicate interpretation. Nevertheless, the study demonstrated that even modest postoperative troponin elevations contain prognostic information. Better recognition may allow earlier identification of patients who need closer monitoring, cardiovascular assessment and optimization of modifiable risk factors. VISION therefore helped broaden the perioperative safety focus beyond the operating room and into the first days after surgery.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
